Long-term human response following subretinal injection of recombinant adenoassociated virus-sFlt-1 vector [ 2011 - 2013 ]

Also known as: Long-term follow-up of human gene therapy

Research Grant

[Cite as]

Researchers: Prof Elizabeth Rakoczy (Principal investigator) ,  Dr Chooi-May Lai Dr Matthew Wikstrom Prof Ian Constable

Brief description Age-related Macular Degeneration (AMD) is the major cause of blindness in the developed world. The present best practice for treating wet AMD is monthly injections of Lucentis� into the eye which is expensive, inconvenient for the patient and has increased risk of infection. The additional assays associated with the clinical trial will test whether adeno-associated virus-mediated gene therapy is safe and whether it can eliminate the need of multiple injections while delivering the same outcome.

Funding Amount $AUD 373,076.33

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]